OK yea I see that in the Q out now.

Decent website and investor info on this.. here..


https://infinittek.com/investor-relations/

SHELL STATUS REMOVED.. $CBGH GOING HIGHER..

https://www.otcmarkets.com/otcapi/company/financial-report/358504/content

SHOULD MAKE SOME GOOD MOVES IMO..
GLTA

Koos is on a mission to get this done. Just keeps putting the next carrot out hoping to catch the wabbit...
IMO there will be backing for the full meal deal in clinical trials.
I am waiting patiently with my pile of free shares for over a year now so the tax break is now out of the way... going to look forward to Rgbp retirement cashout sale in the near term rather than long term its going to happen soon... lol

Regen BioPharma, Inc. Files Provisional Patent Application on Second Generation Survivin mRNA Cancer Immunotherapy...



SAN DIEGO, July 26, 2022 /PRNewswire/ --Regen BioPharma, Inc. RGBP RGBPP, announced today the filing with the United States Patent and Trademark Office of a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented survivin mRNA cancer immunotherapeutic vaccine.

In 2021 the Company was granted US patent # 11,090,332 on composition of matter of survivin modified-mRNA useful for teaching the immune system to kill cancer. In the current patent, specific types of dendritic cells, means of generating specialized dendritic cells, and the planned formulation that will enter clinical trials have been granted patent protection.

We are proud of our collaborators and colleagues who have worked on our first issued survivin patent, which was filed in 2015, before the world realized the potency of modified-mRNA technology that was first successfully commercialized with the COVID-19 vaccines by Moderna and Pfizer, said Dr. David Koos, CEO and Chairman of the Company. The currently filed application discloses means of significantly increasing efficacy by combining modified-mRNA with unique cellular immunotherapy as well as adjuvant approaches. We chose this strategy to maximally protect our intellectual property around this potentially very valuable mRNA cancer immunotherapy vaccine.

Immunotherapy of cancer represents a very large market which is currently being led by the class of drugs called checkpoint inhibitors and CAR-T cells. To date there is no mRNA immunotherapy available for treating cancer. This patent application protects the use of our patented survivin mRNA both as a stand-alone vaccine and as an immunotherapy.

https://www.prnewswire.com/news-releases/regen-biopharma-inc--files-provisional-patent--application-on-second-generation-survivin-mrna-cancer-immunotherapy-vaccine-301593795.html

Acording to Regen website. February 21, 2018 | SOURCE: PRNewswire | Regen BioPharma, Inc. Program to Determine the 3-D Crystal Structure of NR2F6 Progresses to Next Step
Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) has moved into the second stage of its previously-announced program to determine the three-dimensional structure of NR2F6 - with and without its proprietary small molecule drugs bound to it. The object of this structure-determination program is to shed light on how the small molecules bind to and modulate NR2F6 activity.

Best post of the year... thanks Skil

This was the last major reversal..

8X34 REVERSAL JUST CROSSED IN THE CHART.. THIS IS GOING UP..

https://stockcharts.com/h-sc/ui?s=rgbp&p=D&yr=0&mn=3&dy=0&id=p11960084343

Dr. Harry Lander and members of his executive team will be involved with any and all meetings related to the financing and any other matters related to this agreement.


 By: Harry Lander
Its: Chairman and CEOIts: CEO

HE IS BACK IN IT..

Wow.. https://newsfilter.io/articles/8-k-form---current-report-item-801---regen-biopharma-inc-0001589150-filer-27d01be2f68090641cca422de2db816d

SHORT TERM GOALS Spooked many shareholders?

This is all easily short term items for Koos. Alliances and licensing agreements are real Keys here. Biopharms are looking for this IP..

During the coming months I shall endeavor to achieve the following milestones:

SHORT TERM GOALS

1)Settle all outstanding convertible notes payable in order that the Company will have no convertible instruments outstanding.
2)Hire a Chief Scientific Officer
3)Seek out and enter into alliances, co-development agreements and additional licensing agreements with regard to our proprietary mRNA and NR2F6 portfolios.
4)Obtain OTCQB listing for our securities on the OTC Market.
5)Establish a social media presence in order to more easily provide updates to our shareholders, the investment community, the scientific community and the public at large.

I think its greed looking for a fast buck moves the $$$ around the OTC this week then poof alot of tickers GONE. This will turn to a dime and they will have missed these cheapies.

RGBP Getting Just one more piece of a great puzzel put together...



ChemDiv had to turn over the IP too what a bargain for RGBP!

Have not sold a share And looking for a great uptrend thru 2022.
Time to load some more...

Next 8k will be goooood...

Please Then Remove This Quote From Posts:

RGBP brings good things to those who wait!

STRONG POWER HOUR INCOMING!

https://sec.report/Document/0001607062-21-000299/

THANKS DR KOOS!

$RGBP GOING OTC-YIELD TO PINK +NEWS= HUGE..RUN..EMINENT A
Cancer Vaccine Patent Approved August 17th Has not been published to SEC yet. We could see that and last filing needed possibly Monday.

Patent Description..
The invention provides means of generating cellular therapies for cancer through the administration of mRNA that is chemically modified to allow for in vitro entry into cells.

https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332

Other HUGE RGBP Patents:

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&Query=%22regen+biopharma%22&d=PTXT


1. Looks like fidelity traders possibly others can buy now since yield so Monday will be more buying pressure.
2. Pink current opens door to worldwide buying pressure.
3. Peeps will move money from 1000s of non pinks into $RGBP in coming weeks.
4. IMHO This is the perfect storm and could see .06 end of the day Monday. Parabolic run to $1.00+ possible for Regen Biopharma coming weeks.

UP 45% last 2 trading days..



HOPE YOUR NOT MISSING OUT ON THIS ONE! GOOD LUCK TO ALL THIS WEEK!

$RGBP GOING YIELD TO PINK +NEWS=HUGE..RUN..COMING--INFO-->

Cancer Vaccine Patent Approved August 17th Has not been published to SEC yet.

The invention provides means of generating cellular therapies for cancer through the administration of mRNA that is chemically modified to allow for in vitro entry into cells.

https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332

Other HUGE RGBP Patents:

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&Query=%22regen+biopharma%22&d=PTXT


1. Looks like fidelity traders possibly others can buy now since yield so Monday will be more buying pressure.
2. Pink current opens door to worldwide buying pressure.
3. Peeps will move money from 1000s of non pinks into $RGBP in coming weeks.
4. IMHO This is the perfect storm and could see .06 end of the day Monday. Parabolic run to $1.00+ possible for Regen Biopharma coming weeks.

UP 46% last 2 trading days..



I AM NOT MISSING OUT ON THIS ONE! GOOD LUCK TO ALL!

$RGBP GOING YIELD TO PINK SOON +NEWS=HUGE..RUN..COMING$$

Cancer Vaccine Patent Approved August 17th Has not been published to SEC yet.

The invention provides means of generating cellular therapies for cancer through the administration of mRNA that is chemically modified to allow for in vitro entry into cells.

https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332

Other HUGE RGBP Patents:

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&Query=%22regen+biopharma%22&d=PTXT


1. Looks like fidelity traders possibly others can buy now since yield so Monday will be more buying pressure.
2. Pink current opens door to worldwide buying pressure.
3. people will move money from 1000s of non pinks into $RGBP in coming weeks.
4. IMHO This is the perfect storm and could see .06 end of the day Monday. Parabolic run to $1.00+ possible for Regen Biopharma coming weeks.

UP 46% last 2 trading days..



I AM NOT MISSING OUT ON THIS ONE! GOOD LUCK TO ALL!

$RGBP GOING YIELD TO PINK +NEWS=HUGE..RUN..COMING$$-->

Cancer Vaccine Patent Approved August 17th Has not been published to SEC yet.

The invention provides means of generating cellular therapies for cancer through the administration of mRNA that is chemically modified to allow for in vitro entry into cells.

https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332

Other HUGE RGBP Patents:

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&Query=%22regen+biopharma%22&d=PTXT


1. Looks like fidelity traders possibly others can buy now since yield so Monday will be more buying pressure.
2. Pink current opens door to worldwide buying pressure.
3. people will move money from 1000s of non pinks into $RGBP in coming weeks.
4. IMHO This is the perfect storm and could see .06 end of the day Monday. Parabolic run to $1.00+ possible for Regen Biopharma coming weeks.

UP 46% last 2 trading days..



I AM NOT MISSING OUT ON THIS ONE GOOD LUCK TO ALL!

$RGBP GOING YIELD TO PINK +NEWS=HUGE..RUN..COMING$$---INFO-->

Cancer Vaccine Patent Approved August 17th Has not been published to SEC yet.

The invention provides means of generating cellular therapies for cancer through the administration of mRNA that is chemically modified to allow for in vitro entry into cells.

https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332


1. Looks like fidelity traders possibly others can buy now since yield so Monday will be more buying pressure.
2. Pink current opens door to worldwide buying pressure.
3. people will move money from 1000s of non pinks into $RGBP in coming weeks.
4. IMHO This is the perfect storm and could see .06 end of the day Monday. Parabolic run to $1.00+ possible for Regen Biopharma coming weeks.

UP 46% last 2 trading days..



I WON'T MISS OUT ON THIS ONE... GOOD LUCK TO ALL!

$RGBP GOING YIELD TO PINK +NEWS=HUGE..RUN..COMING$$---INFO-->

Cancer Vaccine Patent Approved August 17th Has not been published to SEC yet.

The invention provides means of generating cellular therapies for cancer through the administration of mRNA that is chemically modified to allow for in vitro entry into cells.

https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332


1. Looks like fidelity traders possibly others can buy now since yield so Monday will be more buying pressure.
2. Pink current opens door to worldwide buying pressure.
3. people will move money from 1000s of non pinks into $RGBP in coming weeks.
4. IMHO This is the perfect storm and could see .06 end of the day Monday. Parabolic run to $1.00+ possible for Regen Biopharma coming weeks.

UP 46% last 2 trading days..



GOOD LUCK TO ALL!

Sid... There is no hint of Bankruptcy and there is always a first time for everything.

A $RGBP Buy out is being talked about everywhere you look and listen...
Koos Says..
NO Bankruptcy anyhere in sight...
you have never seen a Bio anthing like this RIGHT admit it!

Just Jearch ..
Regen Buy Out

Search says it all.. Mic Drop....BOOM!

From what I read Public companies must report certain material corporate events on a more current basis. Form 8-K is the “current report” companies must file with the SEC to announce major events that shareholders should know about.

Companies have four business days to file a Form 8-K for the events specified in the items in Sections 1-6 and 9



Seems it would be a change in financial condition in valuation of the company assets in IP. Or Other Events.

Section 1 Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement
Item 1.02 Termination of a Material Definitive Agreement
Item 1.03 Bankruptcy or Receivership
Item 1.04 Mine Safety - Reporting of Shutdowns and Patterns of Violations

Section 2 Financial Information
Item 2.01 Completion of Acquisition or Disposition of Assets
Item 2.02 Results of Operations and Financial Condition
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 2.05 Costs Associated with Exit or Disposal Activities
Item 2.06 Material Impairments

Section 3 Securities and Trading Markets
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02 Unregistered Sales of Equity Securities
Item 3.03 Material Modification to Rights of Security Holders

Section 4 Matters Related to Accountants and Financial Statements
Item 4.01 Changes in Registrant's Certifying Accountant
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Section 5 Corporate Governance and Management
Item 5.01 Changes in Control of Registrant
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
Item 5.05 Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06 Change in Shell Company Status
Item 5.07 Submission of Matters to a Vote of Security Holders
Item 5.08 Shareholder Director Nominations

Section 6 Asset-Backed Securities
Item 6.01 ABS Informational and Computational Material
Item 6.02 Change of Servicer or Trustee
Item 6.03 Change in Credit Enhancement or Other External Support
Item 6.04 Failure to Make a Required Distribution
Item 6.05 Securities Act Updating Disclosure

Section 7 Regulation FD
Item 7.01 Regulation FD Disclosure

Section 8 Other Events
Item 8.01 Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)

Section 9 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits


GUESS WE WILL SEE!

Shouldn't there be 8K Monday for the Patent released August 17th?


United States Patent 11,090,332
Koos , et al. August 17, 2021
Antigen specific mRNA cellular cancer vaccines

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&p=1&f=G&l=50&d=PTXT&S1=%22regen+biopharma%22&OS=%22regen+biopharma%22&RS=%22regen+biopharma%22

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&Query=%22regen+biopharma%22&d=PTXT

Then see final filing to go pink Monday whould be Great!

Traits of Marxism.. A method of socioeconomic analysis that uses a materialist interpretation of historical development, better known as historical materialism, to understand class relations and social conflict as well as a dialectical perspective to view social transformation. Lol

3 Reasons $RGBP Could Be Sold For CASH$$

1) The Company is Down, But Not Out.

2) The Science is MRNA Blockbuster But Bank Account isn’t.

3) Dr Koos is near the End of a long Career.

Thanks to OTCShotcaller Here's Reason #4

#4- It's going to take hundreds of millions of dollars to put the re-activated Patents into FDA Approved Clinical Trials.

Here's a link that provides an estimate for this.

https://www.jhsph.edu/news/news-releases/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab.html

The average or "median" cost in 2015-2016 was $16 Million per clinical trial. Today it would be much higher.

Also, this article points out that for clinical trials that involve examining "a drug's ability to prevent a clinically meaningful outcome..", the median cost is much higher, i.e. $65 Million per trial, and again that was back in 2015-2016.

So yes as I said, to put those re-activated Patents into clinical trials is going to cost a absolute FORTUNE....ALL CASH!!

Big Pharma Buy Out is the only thing that makes sense, IMO.

Opinion Only..

Thanks To Longs Here Great Close.. 10Q Next..

Push Past .04 Lookin For Blue Sky...$$$

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Certified the 10Q

https://www.sec.gov/Archives/edgar/data/1589150/000160706221000282/ex31_1.htm

Maybe he will talk after this yield sign changes to OTCQB pink current in a couple days..

Exactly there are alot of moving parts here..

Why not just ask him these questions?


Telephone: (619) 722-5505 ext: 800
Fax: (619) 330-2328
Email: david.koos@regenbiopharma.com

$RGBP Yield sign went up today!!!Pink coming soon...Runner! https://www.otcmarkets.com/stock/RGBP/disclosure

$RGBP Yield sign went up today!!!Pink coming soon...Runner! https://www.otcmarkets.com/stock/RGBP/disclosure

$RGBP Yield sign went up today!!!Pink coming soon... Another Big run coming...

https://www.otcmarkets.com/stock/RGBP/disclosure

Oh MMs Just doing their job filling orders for themselves holding it hostage for their profiting pleasure.

Its the shareholders turn next..

MMs and there minions here are crooks.

Koos has been sayin
This is about to LAUNCH....

Thanks for the Sticky post...I think a new base.03-.04 is coming today..

Same here Good luck to all longs. Many Millionaires will be made here..